BioCentriq is a highly collaborative CDMO focused exclusively on cell and gene therapy. Its facilities and services are designed to meet the needs of early-stage biotech companies bringing promising therapeutic candidates from bench to clinic.

In addition to custom development and manufacturing services, BioCentriq offers its LEAPTM Advanced Therapy Platform which helps early-stage biotech companies go from contract to clinic in as short as six months.